Related Experiment Video
Updated: Aug 9, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
Pathogenic human monoclonal antibody against desmoglein 3
Shih-Wei Yeh1, Lisa A Cavacini, Kailash C Bhol
1Department of Oral Medicine, Harvard School of Dental Medicine, Boston, MA 02115, USA.
A novel human monoclonal antibody, PVMAB786, targets desmoglein 3 (Dsg3) in pemphigus vulgaris (PV). This antibody successfully models PV pathogenesis in mice, offering a new tool for research.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Pemphigus vulgaris (PV) is a severe autoimmune disease.
- It involves IgG autoantibodies targeting desmoglein 3 (Dsg3).
- Dsg3 is crucial for epidermal keratinocyte adhesion.
Purpose of the Study:
- To characterize a novel human monoclonal antibody, PVMAB786.
- To investigate its potential as a research tool for PV.
Main Methods:
- Isolation of PVMAB786 from an untreated PV patient.
- Testing antibody reactivity against keratinocytes and recombinant Dsg3.
- Inducing acantholysis in human tissues and a mouse model.
Main Results:
- PVMAB786 is a Dsg3-specific IgG4 antibody.
- It binds to Dsg3 on keratinocytes and recombinant Dsg3, not Dsg1.
- The antibody induced acantholysis and mimicked PV in mice.
Conclusions:
- PVMAB786 is a valuable tool for studying Dsg3's role in PV.
- It aids research into epithelial cell adhesion and acantholysis mechanisms.
- Further research can explore Dsg3 processing, presentation, and V gene/isotype usage in PV.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012